Perceptive Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.1M Sell
280,541
-35,000
-11% -$4.89M 0.65% 36
2025
Q4
$51.7M Buy
315,541
+45,113
+17% +$7.07M 0.92% 33
2025
Q3
$36.1M Buy
270,428
+104,428
+63% +$12.7M 1.04% 28
2025
Q2
$20.6M Buy
166,000
+36,199
+28% +$4.61M 0.77% 37
2025
Q1
$16.5M Buy
+129,801
New +$20M 0.58% 39
2021
Q3
Sell
-132,500
Closed -$26.4M 154
2021
Q2
$26.4M Buy
+132,500
New +$25.7M 0.34% 71
2021
Q1
Sell
-97,500
Closed -$18.7M 158
2020
Q4
$18.7M Buy
+97,500
New +$17.7M 0.2% 88
2017
Q4
Sell
-87,400
Closed -$3.35M 149
2017
Q3
$3.35M Buy
+87,400
New +$3.66M 0.13% 81

Other funds holding RGEN

Perceptive Advisors's RGEN Position: Q1 2026 in Review

Perceptive Advisors reduced its Repligen (RGEN) stake by 11% in Q1 2026, selling an estimated $4.89M and leaving 280,541 shares worth $33.1M. The position accounts for 0.65% of the portfolio, ranked #36.

Perceptive Advisors first reported a position in RGEN in Q3 2017 and has held it in 8 quarters since. The position peaked at $51.7M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Perceptive Advisors held 280,541 shares of Repligen worth $33.1M as of Q1 2026.
  • Perceptive Advisors sold 35,000 Repligen shares in Q1 2026, an estimated $4.89M.
  • Repligen made up 0.65% of Perceptive Advisors's portfolio in Q1 2026, its #36 holding.
  • Perceptive Advisors first reported a position in Repligen in Q3 2017 and has held it in 8 quarters since.
  • Perceptive Advisors's Repligen position peaked at $51.7M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.